About: http://data.cimple.eu/news-article/fac3d83f868cc4c2d46c42dbec5bc29d7a2824c852e878dc84adc060     Goto   Sponge   NotDistinct   Permalink

An Entity of Type : schema:NewsArticle, within Data Space : data.cimple.eu associated with source document(s)

AttributesValues
rdf:type
schema:articleBody
  • The World Health Organization on Wednesday offered its backing to the coronavirus vaccine made by embattled drug company AstraZeneca, as one of its experts exchanged barbs with the US government over a controversial mission to probe the pandemic's origins in China. The WHO said AstraZeneca's jabs could be used on people aged over 65 and also in places where new variants of Covid-19 are circulating, following recent questions over the efficacy of the British-Swedish firm's vaccine. And there was further good news for AstraZeneca as the company announced it would work with German firm IDT Biologika to produce more vaccines for Europe, where shortages of doses have sparked a bitter dispute with the EU. Covid-19 has killed more than 2.3 million people since emerging in China in late 2019, exerting a firm grip over people's lives across the world with lockdowns, curfews and business closures. Germany looked set to prolong its restrictions as the European Union passed 500,000 deaths on Wednesday, with many EU countries struggling to get momentum behind their vaccine rollouts. The EU's top official admitted in a public forum for the first time that the bloc had botched some aspects of its vaccine strategy. "We were late to authorise. We were too optimistic when it came to massive production," European Commission chief Ursula von der Leyen told the European Parliament. Even Russia, widely hailed for its homegrown Sputnik V jab, had only managed to fully vaccinate just over two million, two months into its programme. Questions over the handling of the initial outbreak have meanwhile sparked an intense diplomatic row between Washington and Beijing. A joint Chinese-WHO mission to the ground zero city of Wuhan wrapped up on Tuesday without any concrete answers, and US officials said they would not accept the findings before verification with their own intelligence. The jibe prompted WHO team member Peter Daszak to tweet: "Please don't rely too much on US intel: increasingly disengaged under Trump & frankly wrong on many aspects." Hundreds of millions of people are still living under severe restrictions including curfews and full lockdowns, and many businesses are beginning to take a more strident tone with their governments. "We are suffocating," read a banner at a rally in Greece's capital Athens, where hundreds of restaurant owners dropped their keys in a box to give to the government as a symbol of their despondency. Greece, which has been under severe restrictions since late last year, will face an even tighter regime from Thursday as Prime Minister Kyriakos Mitsotakis warned of a third wave. Frustrations were also boiling over in Israel, where security forces and ultra-orthodox Jews clashed in the latest in a series of protests against coronavirus restrictions. "Stop the harassment of religion on health grounds," read one banner, highlighting that curbs are being lifted more slowly in ultra-orthodox districts because of higher infection rates. Israel has so far given more than 40 percent of its population at least one vaccine shot, leaving other parts of the world to play catch-up. Peru on Tuesday began administering shots developed by China's Sinopharm, while Argentina approved the Indian-made version of the AstraZeneca vaccine. South Korea on Wednesday also authorised the AstraZeneca shot for people aged 18 and above, including over-65s. Japan will start vaccinations next week -- most likely the Pfizer/BioNTech jab -- but it is scrambling to secure suitable syringes so doses are not wasted. AstraZeneca has faced a tough few weeks, with European leaders casting doubt on the efficacy of its jabs for over-65s and a small South African study suggesting it performed badly against their local strain. Before Wednesday's announcements from the WHO, South African officials said they were considering selling or swapping the jabs they had already bought, opting to stock up on another vaccine made by rival Johnson & Johnson. "There are already countries who are asking to sell it to them," said Health Minister Zweli Mkhize. As vaccine rollouts rumble on, governments still face the thorny issue of persuading restless populations to abide by social-distancing rules -- a particular problem this weekend when couples will look for a way to mark Valentine's Day on Sunday. Thailand's capital Bangkok has banned people from getting married on the day, usually a popular time for weddings. In Brussels, entrepreneurs are trying to enable some kind of celebration, with hotels converting rooms into private dining salons for two. "We're over the moon about being here tonight, just like in a restaurant," said Marine Deroo, a 34-year-old who tried out the concept ahead of Valentine's Day. burs-jxb/kjl/har
schema:headline
  • WHO backs AstraZeneca as expert trades barbs with US
schema:mentions
schema:author
schema:datePublished
http://data.cimple...sPoliticalLeaning
http://data.cimple...logy#hasSentiment
http://data.cimple...readability_score
http://data.cimple...tology#hasEmotion
http://data.cimple...entionsConspiracy
Faceted Search & Find service v1.16.115 as of Oct 09 2023


Alternative Linked Data Documents: ODE     Content Formats:   [cxml] [csv]     RDF   [text] [turtle] [ld+json] [rdf+json] [rdf+xml]     ODATA   [atom+xml] [odata+json]     Microdata   [microdata+json] [html]    About   
This material is Open Knowledge   W3C Semantic Web Technology [RDF Data] Valid XHTML + RDFa
OpenLink Virtuoso version 07.20.3238 as of Jul 16 2024, on Linux (x86_64-pc-linux-musl), Single-Server Edition (126 GB total memory, 11 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software